tiprankstipranks
TipRanksTop Financial ExpertsInsidersMartine Rothblatt

Martine Rothblatt Insider Profile

11 Followers
Martine Rothblatt, Chairperson & CEO, Director at United Therapeutics, holds 668.73K shares in United Therapeutics (Ticker: UTHR), holds 8.21K shares in BETA Technologies, Inc. Class A (Ticker: BETA).
See the Hottest Stocks Based on Insider Trading >
tipranks
Martine Rothblatt

Martine Rothblatt
United Therapeutics (UTHR)
Chairperson & CEO, Director

Ranked #55,994 out of 108,136 Corporate Insiders

Profitable Transactions

53%
8 out of 15 Profitable Transactions

Average Return

-0.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$370M
99.96%
0.04%
A breakdown of Martine Rothblatt's holdings
See the Top Stocks by Insiders

Insider Roles

United Therapeutics
(UTHR)
Chairperson & CEO, Director
BETA Technologies, Inc. Class A
(BETA)
Director
Roles that Martine Rothblatt holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
United Therapeutics
(UTHR)
Rating:Informative Sell
Date:Jun 03, 2015 - Jun 03, 2016
Return:+36.70%
The most profitable trade made by Martine Rothblatt
See the Latest Stocks Traded by Insiders

Martine Rothblatt's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
UTHR
United Therapeutics
Jul 09, 2026
Chairperson & CEO, Director
Uninformative Buy
1.29M
$369.46M
BETA
BETA Technologies, Inc. Class A
Jun 12, 2026
Director
Uninformative Buy
―
$137.40K
List of latest transactions for each holding click on a transaction to see Martine Rothblatt's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Martine Rothblatt insider profile FAQ

What is the percentage of profitable transactions made by Martine Rothblatt?
The percentage of profitable transactions made by Martine Rothblatt is 53%.
    What is the average return per transaction made by Martine Rothblatt?
    The average return per transaction made by Martine Rothblatt is -0.50%.
      What stocks does Martine Rothblatt hold?
      Martine Rothblatt holds: UTHR, BETA stocks.
        What was Martine Rothblatt’s latest transaction?
        Martine Rothblatt latest transaction was an Uninformative Buy of $1.29M.
          What was Martine Rothblatt's most profitable transaction?
          Martine Rothblatt’s most profitable transaction was an Informative Sell of UTHR stock on June 3, 2015. The return on the trade was 36.70%.
            What is Martine Rothblatt's role in United Therapeutics?
            Martine Rothblatt's role in United Therapeutics is Chairperson & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.